The American Society for Microbiology published an article detailing the significance of why antimicrobial susceptibility testing in clinical labs is essential to patient care.

In Jan. 2022, a publication was released that summarized the worldwide impact of antimicrobial resistance (AMR) in 2019. This study concluded that there were an estimated 4.95 million deaths associated with bacterial AMR across the globe in 2019, considerably more than previously estimated.

This highlights the importance of antimicrobial susceptibility testing, reporting and surveillance in preventing and managing infections caused by resistant organisms.

Data transparency and susceptibility testing in the clinical laboratory are more important than ever before.

Read the full article at